Literature DB >> 10735705

Surgical closure of apical ventricular septal defects through a right ventricular apical infundibulotomy.

G Stellin1, M Padalino, O Milanesi, M Rubino, D Casarotto, R Van Praagh, S Van Praagh.   

Abstract

BACKGROUND: We present a new understanding of the anatomic position of apical ventricular septal defects and its surgical relevance. These defects occur between the left ventricular apex and the infundibular apex, rather than between the left and right ventricular apices. Often a sizable apical recess, the infundibular apex lies anteriorly and inferiorly to the moderator band and is the most leftward part of the right ventricle.
METHODS: Four patients (2 boys and 2 girls) with a mean age of 109 days (range, 48 to 217 days) underwent patch closure through an apical infundibulotomy, which allowed complete visualization of the muscular apical ventricular septal defect.
RESULTS: There were no early or late deaths at operation. No significant residual shunt at ventricular level was detected by postoperative two-dimensional and Doppler echocardiography. Intraoperative comparison of right atrial and pulmonary arterial blood samples showed a difference of less than 5%. At a mean follow-up of 18 months, all the patients are asymptomatic and growing well.
CONCLUSIONS: The successful outcome of these 4 patients indicates that surgical closure of apical ventricular septal defects can be achieved safely and completely in early infancy through a limited right ventricular apical infundibulotomy. Long-term follow-up of these and similar patients is needed to provide further evaluation of this approach.

Entities:  

Mesh:

Year:  2000        PMID: 10735705     DOI: 10.1016/s0003-4975(99)01333-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

Review 1.  Surgical management of muscular trabecular ventricular septal defects.

Authors:  Toshihide Asou
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-11-15

2.  Surgical closure of an apical ventricular septal defect through a septal ventriculotomy.

Authors:  Shin Takabayashi; Shin Shomura; Masaki Kajimoto; Yasuhiro Sawada; Kentaro Inoue; Hideto Shimpo
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-04

3.  Virtual cardiotomy based on 3-D MRI for preoperative planning in congenital heart disease.

Authors:  Thomas Sangild Sørensen; Philipp Beerbaum; Jesper Mosegaard; Allan Rasmusson; Tobias Schaeffter; Conal Austin; Reza Razavi; Gerald Franz Greil
Journal:  Pediatr Radiol       Date:  2008-10-25

4.  Perventricular device closure of isolated muscular ventricular septal defect in infants: a single centre experience.

Authors:  Bhavesh Thakkar; Nehal Patel; Shaunak Shah; Vishal Poptani; Tarun Madan; Chirag Shah; Anand Shukla; Vaishali Prajapati
Journal:  Indian Heart J       Date:  2012-09-12

Review 5.  Techniques and results in the management of multiple muscular trabecular ventricular septal defects.

Authors:  Tetsuya Kitagawa; Takashi Kitaichi; Mikio Sugano; Hirotsugu Kurobe
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-06-05

6.  Ventricular septal defects: morphology of the doubly committed juxtaarterial and muscular variants.

Authors:  K McCarthy; S Ho; R Anderson
Journal:  Images Paediatr Cardiol       Date:  2000-07

7.  Multiple ventricular septal defects: a new strategy.

Authors:  Antonio F Corno; Pramod R Kandakure; Ramana Rao V Dhannapuneni; Gordon Gladman; Prem Venugopal; Nelson Alphonso
Journal:  Front Pediatr       Date:  2013-07-31       Impact factor: 3.418

8.  Late surgical repair of a traumatic ventricular septal defect.

Authors:  Leanne Harling; Hutan Ashrafian; Roberto P Casula; Thanos Athanasiou
Journal:  J Cardiothorac Surg       Date:  2014-09-20       Impact factor: 1.637

9.  Percardiac closure of large apical ventricular septal defects in infants: Novel modifications and mid-term results.

Authors:  Geoffrey J Changwe; Li Hongxin; Hai-Zhou Zhang; Guo Wenbin; Fei Liang; Xing-Xu Cao; Shan-Liang Chen
Journal:  J Card Surg       Date:  2021-01-27       Impact factor: 1.620

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.